CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
3.400
-0.050 (-1.45%)
Nov 21, 2024, 11:25 AM EST - Market open
CalciMedica Employees
CalciMedica had 12 employees as of December 31, 2021.
Employees
12
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,132,333
Market Cap
45.80M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2021 | 12 | - | - |
Related Stocks
Company Name | Employees |
---|---|
CareCloud | 3,600 |
SHL Telemedicine | 583 |
Affimed | 76 |
Xilio Therapeutics | 73 |
Actinium Pharmaceuticals | 49 |
Calidi Biotherapeutics | 41 |
Gain Therapeutics | 32 |
SCYNEXIS | 29 |
CALC News
- 6 hours ago - CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference - PRNewsWire
- 22 hours ago - CalciMedica Announces Presentations at Upcoming Medical Meetings - PRNewsWire
- 8 days ago - CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates - PRNewsWire
- 14 days ago - CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer - PRNewsWire
- 21 days ago - CalciMedica Announces Pricing of Public Offering of Common Stock - PRNewsWire
- 21 days ago - CalciMedica Announces Proposed Public Offering of Common Stock - PRNewsWire
- 22 days ago - CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting - PRNewsWire
- 23 days ago - CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) - PRNewsWire